Genscript Biotech Corporation (GNNSF)
Operating Cash Flow
$377.89M
TTM · Period ending: · USD

GNNSF Operating Cash Flow
What is operating cash flow?
Cash generated from core business operations.
Compare operating cash flow
GNNSF operating cash flow history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Operating Cash Flow (USD) | Change |
|---|---|---|
| 325,522,000 | +330.32% | |
| 75,647,000 | — | |
| -286,911,000 | — | |
| -120,292,000 | — | |
| -136,790,000 | — | |
| -151,093,000 | — | |
| -29,955,000 | −110.14% | |
| 295,412,000 | +1,282.50% | |
| 21,368,000 | −35.78% | |
| 33,275,000 | +69.46% | |
| 19,636,000 | +60.87% | |
| 12,206,000 | +1.51% | |
| 12,024,000 | — |
Frequently asked questions: GNNSF operating cash flow
What is Genscript Biotech Corporation (GNNSF)'s current operating cash flow?
Genscript Biotech Corporation (GNNSF)'s latest reported operating cash flow (TTM) is $377.89M as of Jun 30, 2026. Cash generated from core business operations.
How much historical operating cash flow data is available for GNNSF?
Stock Alarm Pro provides 13 dated annual fiscal periods observations for Genscript Biotech Corporation (GNNSF)'s operating cash flow, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare GNNSF's operating cash flow to peers or set an alert?
You can compare GNNSF's operating cash flow directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on GNNSF delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance